Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2003

Open Access 01-12-2003 | Editorial

Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist?

Authors: Steven D Heys, Shailesh Chaturvedi

Published in: World Journal of Surgical Oncology | Issue 1/2003

Login to get access

Excerpt

For the last 2000 years surgery has been the primary treatment for patients with breast cancer. During this period, surgical procedures for breast cancer became more extensive and culminated in the radical mastectomy as described by Halstead. Such extensive surgery was fuelled, and perpetuated, by the widespread acceptance of the Halsteadian concept of tumour biology and tumour spread. As a result of this, radical mastectomy dominated surgical practice for breast cancer for almost 100 years [1]. However, with advances in our understanding of tumour biology, these Halsteadian concepts were challenged. As a result, novel, and less extensive, approaches to the surgical treatment of breast cancer were initiated and evaluated in a scientific manner. …
Literature
1.
go back to reference Halstead WS: The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907, 46: 1-19.CrossRef Halstead WS: The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907, 46: 1-19.CrossRef
2.
go back to reference Early Breast Cancer Trialists Collaborative Group: Polychemotherapy for breast cancer: an overview of randomised trials. Lancet. 1998, 352: 930-942. 10.1016/S0140-6736(98)03301-7.CrossRef Early Breast Cancer Trialists Collaborative Group: Polychemotherapy for breast cancer: an overview of randomised trials. Lancet. 1998, 352: 930-942. 10.1016/S0140-6736(98)03301-7.CrossRef
4.
go back to reference Sheldon PW, Fowler JF: The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer. 1973, 28: 508-514.PubMedCentralCrossRefPubMed Sheldon PW, Fowler JF: The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer. 1973, 28: 508-514.PubMedCentralCrossRefPubMed
5.
go back to reference Fisher B, Gunduz N, Saffer EA: Influence of the interval between primary tumour removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983, 43: 1488-1492.PubMed Fisher B, Gunduz N, Saffer EA: Influence of the interval between primary tumour removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983, 43: 1488-1492.PubMed
6.
go back to reference De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G.: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemotherap Pharmacol. 1978, 1: 53-59.CrossRef De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G.: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemotherap Pharmacol. 1978, 1: 53-59.CrossRef
7.
go back to reference Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, Housset M, Forget G, Thill L, Soubrane C, Khayat D: Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 1990, 66: 119-129.CrossRefPubMed Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, Housset M, Forget G, Thill L, Soubrane C, Khayat D: Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 1990, 66: 119-129.CrossRefPubMed
8.
go back to reference Smith IE, Jones AL, O'Brien ME, McKinna JA, Sacks N, Baum M: Primary medical (neoadjuvant) chemotherapy for operable breast cancer. Eur J Cancer. 1993, 29: 592-595.CrossRef Smith IE, Jones AL, O'Brien ME, McKinna JA, Sacks N, Baum M: Primary medical (neoadjuvant) chemotherapy for operable breast cancer. Eur J Cancer. 1993, 29: 592-595.CrossRef
9.
go back to reference Swain SM, Sorace RA, Bagley CS, Danforth DN, Bader J, Wesley MN, Steinberg SM, Lippman ME: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 1987, 47: 3889-3894.PubMed Swain SM, Sorace RA, Bagley CS, Danforth DN, Bader J, Wesley MN, Steinberg SM, Lippman ME: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 1987, 47: 3889-3894.PubMed
10.
go back to reference Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, Ah-See AK, Eremin O, Walker LG, Sarkar TK, Eggleton SP, Ogston KN: Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002, 20: 1456-1466. 10.1200/JCO.20.6.1456.CrossRefPubMed Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, Ah-See AK, Eremin O, Walker LG, Sarkar TK, Eggleton SP, Ogston KN: Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002, 20: 1456-1466. 10.1200/JCO.20.6.1456.CrossRefPubMed
11.
go back to reference NSABP: The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide; preliminary results from NSABP protocol B-27. Breast Cancer Res Treat. 2001, 69: 210- NSABP: The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide; preliminary results from NSABP protocol B-27. Breast Cancer Res Treat. 2001, 69: 210-
12.
go back to reference Amat S, Bougnoux P, Penault-Llorca F, Fetissof F, Cure H, Kwiatkowski F, Achard JL, Body G, Dauplat J, Chollet P: Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer. 2003, 88: 1339-1345. 10.1038/sj.bjc.6600916.PubMedCentralCrossRefPubMed Amat S, Bougnoux P, Penault-Llorca F, Fetissof F, Cure H, Kwiatkowski F, Achard JL, Body G, Dauplat J, Chollet P: Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer. 2003, 88: 1339-1345. 10.1038/sj.bjc.6600916.PubMedCentralCrossRefPubMed
13.
go back to reference Bonnadona G, Valagussa P: Primary chemotherapy in operable breast cancer. Semin Oncol. 1996, 23: 464-474. Bonnadona G, Valagussa P: Primary chemotherapy in operable breast cancer. Semin Oncol. 1996, 23: 464-474.
14.
go back to reference Simmo Simmonds PD, Mead GM, Lee AH, Theaker JM, Dewbury K, Smart CJ: Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?. Cancer. 1995, 75: 1018-1024.CrossRefPubMed Simmo Simmonds PD, Mead GM, Lee AH, Theaker JM, Dewbury K, Smart CJ: Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?. Cancer. 1995, 75: 1018-1024.CrossRefPubMed
15.
go back to reference Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB, Hoehn JL, Lees AW, Dimitrov NV, Bear HD: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998, 16: 2672-2685.PubMed Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB, Hoehn JL, Lees AW, Dimitrov NV, Bear HD: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998, 16: 2672-2685.PubMed
16.
go back to reference McIntosh SA, Ogston KN, Payne S, Miller ID, Sarkar TK, Hutcheon AW, Heys SD: Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg. 2003, 185: 525-531. 10.1016/S0002-9610(03)00078-3.CrossRefPubMed McIntosh SA, Ogston KN, Payne S, Miller ID, Sarkar TK, Hutcheon AW, Heys SD: Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg. 2003, 185: 525-531. 10.1016/S0002-9610(03)00078-3.CrossRefPubMed
17.
go back to reference Woolmark N, Wang J, Mamounas E, Bryant J, Fisher B: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001, 30: 96-102.CrossRef Woolmark N, Wang J, Mamounas E, Bryant J, Fisher B: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001, 30: 96-102.CrossRef
18.
go back to reference Menges M, Schmidt C, Lindemann W, Ridwelski K, Pueschel W, Jungling B, Feifel G, Schilling M, Stallmach A, Zeitz M: Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol. 2003 Jun 27 [Epub ahead of print] PMID: 12836016 Menges M, Schmidt C, Lindemann W, Ridwelski K, Pueschel W, Jungling B, Feifel G, Schilling M, Stallmach A, Zeitz M: Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol. 2003 Jun 27 [Epub ahead of print] PMID: 12836016
19.
go back to reference Urschel JD, Vasan H: A meta-analysis of randomised controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003, 185: 538-543. 10.1016/S0002-9610(03)00066-7.CrossRefPubMed Urschel JD, Vasan H: A meta-analysis of randomised controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003, 185: 538-543. 10.1016/S0002-9610(03)00066-7.CrossRefPubMed
20.
go back to reference DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003, 56: 1117-1127. 10.1016/S0360-3016(03)00186-X.CrossRefPubMed DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003, 56: 1117-1127. 10.1016/S0360-3016(03)00186-X.CrossRefPubMed
21.
go back to reference Mazzeo F, Berliere M, Kerger J, Squifflet J, Duck L, D'Hondt V, Humblet Y, Donnez J, Machiels JP: Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable advanced-stage ovarian cancer. Gynecol Oncol. 2003, 90: 163-169. 10.1016/S0090-8258(03)00249-X.CrossRefPubMed Mazzeo F, Berliere M, Kerger J, Squifflet J, Duck L, D'Hondt V, Humblet Y, Donnez J, Machiels JP: Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable advanced-stage ovarian cancer. Gynecol Oncol. 2003, 90: 163-169. 10.1016/S0090-8258(03)00249-X.CrossRefPubMed
22.
go back to reference De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E: Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC). Am J Clin Oncol. 2003, 26: 265-269. 10.1097/00000421-200306000-00012.PubMed De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E: Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC). Am J Clin Oncol. 2003, 26: 265-269. 10.1097/00000421-200306000-00012.PubMed
23.
go back to reference Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L: The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomised trial. Eur J Gynaecol Oncol. 2003, 24: 51-59.PubMed Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L: The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomised trial. Eur J Gynaecol Oncol. 2003, 24: 51-59.PubMed
Metadata
Title
Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist?
Authors
Steven D Heys
Shailesh Chaturvedi
Publication date
01-12-2003
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2003
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-1-14

Other articles of this Issue 1/2003

World Journal of Surgical Oncology 1/2003 Go to the issue